Literature DB >> 7987334

A 7 bp deletion of the RET proto-oncogene in familial Hirschsprung's disease.

T Attie1, A Pelet, P Sarda, C Eng, P Edery, L M Mulligan, B A Ponder, A Munnich, S Lyonnet.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 7987334     DOI： 10.1093/hmg/3.8.1439

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN： 0964-6906            Impact factor:   6.150


× No keyword cloud information.
  5 in total

1.  Molecular heterogeneity of RET loss of function in Hirschsprung's disease.

Authors:  F Carlomagno; G De Vita; M T Berlingieri; V de Franciscis; R M Melillo; V Colantuoni; M H Kraus; P P Di Fiore; A Fusco; M Santoro
Journal:  EMBO J       Date:  1996-06-03       Impact factor: 11.598

2.  Shc and Enigma are both required for mitogenic signaling by Ret/ptc2.

Authors:  K Durick; G N Gill; S S Taylor
Journal:  Mol Cell Biol       Date:  1998-04       Impact factor: 4.272

Review 3.  Hirschsprung's disease as a neurochristopathy.

Authors:  G Martucciello
Journal:  Pediatr Surg Int       Date:  1997       Impact factor: 1.827

4.  Oncological implications of RET gene mutations in Hirschsprung's disease.

Authors:  R H Sijmons; R M Hofstra; F A Wijburg; T P Links; R P Zwierstra; A Vermey; D C Aronson; G Tan-Sindhunata; G J Brouwers-Smalbraak; S M Maas; C H Buys
Journal:  Gut       Date:  1998-10       Impact factor: 23.059

Review 5.  Mouse models of Hirschsprung disease and other developmental disorders of the enteric nervous system: Old and new players.

Authors:  Nadege Bondurand; E Michelle Southard-Smith
Journal:  Dev Biol       Date:  2016-06-28       Impact factor: 3.582
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.